Invirsa, Inc Email Format

Pharmaceutical ManufacturingOhio, United States11-50 Employees

Invirsa, Inc is a clinical-stage pharmaceutical company focused on developing therapies for ocular diseases rooted in genomic dysfunction. Its lead candidate, INV-102, targets diabetic eye conditions by countering pathological PARylation to restore genome architecture and promote repair, aiming to improve healing in conditions such as non-healing corneal ulcers and keratopathy. The company positions its work at the intersection of molecular biology and ophthalmology, seeking to address an underlying cause of vision-related diseases rather than treating symptoms alone. Based in Columbus, Ohio, Invirsa operates in the pharmaceutical manufacturing space with a focus on small-molecule therapeutics and related ocular indications. The organization is positioned as a specialized, early-stage enterprise pursuing a targeted portfolio grounded in genomic mechanisms that influence tissue repair and immune-modulatory effects in eye diseases. A recent development highlights progress in its clinical program, with Phase 2 data indicating statistically significant improvements in visual acuity for diabetic subjects, reflecting mechanism-specific effects observed in its trials.

Sign up for free to view info

Company overview Employee directory